Trial Outcomes & Findings for Cerebromicrovascular Effects of Time-Restricted Eating in Older Adults (NCT NCT05488652)

NCT ID: NCT05488652

Last Updated: 2026-08-17

Results Overview

Functional near infrared spectroscopy (fNIRS) will be performed during the cognitive n-back task. fNIRS approach generates data that represent a relative change in oxygenated hemoglobin measured over the cortical brain tissues. fNIRS data is analyzed using a pipeline based on the General Linear Model (GLM) approach created using the Brain AnalyzIR toolbox and implemented in MatLab. At the subject level, regression coefficients (beta values) are extracted to characterize individual neurovascular coupling response in the prefrontal cortex across all n-back blocks. It is expected that more difficult cognitive tasks will lead to increased neurovascular coupling responses in healthy individuals, but no clinically relevant ranges exist for this measure.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

11 participants

Primary outcome timeframe

Baseline, 6 months

Results posted on

2026-08-17

Participant Flow

Participant milestones

Participant milestones
Measure
Time Restricted Eating
Assigned to adhere to a 14:10 daily fasting regimen for 6 months
Overall Study
STARTED
11
Overall Study
COMPLETED
6
Overall Study
NOT COMPLETED
5

Reasons for withdrawal

Reasons for withdrawal
Measure
Time Restricted Eating
Assigned to adhere to a 14:10 daily fasting regimen for 6 months
Overall Study
Withdrawal by Subject
4
Overall Study
Lost to Follow-up
1

Baseline Characteristics

Cerebromicrovascular Effects of Time-Restricted Eating in Older Adults

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Time Restricted Eating
n=11 Participants
Assigned to adhere to a 14:10 daily fasting regimen for 6 months
Age, Categorical
<=18 years
0 Participants
n=51 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
n=51 Participants
Age, Categorical
>=65 years
1 Participants
n=51 Participants
Sex: Female, Male
Female
10 Participants
n=51 Participants
Sex: Female, Male
Male
1 Participants
n=51 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=51 Participants
Race (NIH/OMB)
Asian
2 Participants
n=51 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=51 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=51 Participants
Race (NIH/OMB)
White
9 Participants
n=51 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=51 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=51 Participants
Age, Continuous
53.6 Years
STANDARD_DEVIATION 8.0 • n=51 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants
n=51 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
10 Participants
n=51 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=51 Participants
BMI
30.3 kg/m^2
STANDARD_DEVIATION 6.2 • n=51 Participants
Godin Leisure-Time Exercise Questionnaire
Active
9 Participants
n=51 Participants
Godin Leisure-Time Exercise Questionnaire
Insufficiently Active/Sedentary
2 Participants
n=51 Participants

PRIMARY outcome

Timeframe: Baseline, 6 months

Population: Only secondary completers are included in the reporting. Average regression coefficients (beta values) are reported for comparisons in neurovascular coupling response between the most challenging vs less challenging tasks (2-back vs 1-back). Only beta values with false-discovery rate-corrected p\<0.05 were included in the analysis.

Functional near infrared spectroscopy (fNIRS) will be performed during the cognitive n-back task. fNIRS approach generates data that represent a relative change in oxygenated hemoglobin measured over the cortical brain tissues. fNIRS data is analyzed using a pipeline based on the General Linear Model (GLM) approach created using the Brain AnalyzIR toolbox and implemented in MatLab. At the subject level, regression coefficients (beta values) are extracted to characterize individual neurovascular coupling response in the prefrontal cortex across all n-back blocks. It is expected that more difficult cognitive tasks will lead to increased neurovascular coupling responses in healthy individuals, but no clinically relevant ranges exist for this measure.

Outcome measures

Outcome measures
Measure
Endpoint
n=6 Participants
After 6 months of 14:10 daily fasting regimen
Baseline
n=6 Participants
Prior to intervention start
Neurovascular Coupling Using Functional Near Infrared Spectroscopy (fNIRS)
32.3 Beta value
Standard Deviation 44.9
-4.6 Beta value
Standard Deviation 4.9

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: Data were not collected due to study participants preference not to participate in this data collection, which requires retina dilation.

Flicker light-induced dilation of the retinal vessels (percentage increase over baseline diameter) will be measured in the right or left eye of each study participant using the Dynamic Vessel Analyzer (DVA, IMEDOS Systems, Jena, Germany). The change in retinal vessel diameters is tracked and reported as a %change from baseline, before and after treatment.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: Data were not collected due to closed acoustic window in study population, which precluded adequate signal acquisition of the middle cerebral artery.

Transcranial Doppler sonography will be used to measure the change in the blood flow velocities during the cognitive n-back task between before and after treatment.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: Only secondary completers are included in the reporting. One participant was excluded due to equipment malfunction on visit 1.

Changes in microvascular endothelial function will be assessed using laser speckle contrast imaging (LSCI) in the hand using the flow mediated dilation approach. The change in skin perfusion is calculated and reported as a fold change from baseline.

Outcome measures

Outcome measures
Measure
Endpoint
n=5 Participants
After 6 months of 14:10 daily fasting regimen
Baseline
n=5 Participants
Prior to intervention start
Microvascular Endothelial Function
3.19 fold change from baseline
Interval 1.68 to 5.62
3.36 fold change from baseline
Interval 1.83 to 4.03

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: Only secondary completers are included in the reporting. Two participants were excluded due to poor data quality.

Changes in macrovascular endothelial function will be assessed using sonography during flow mediated dilation approach. The change in brachial artery diameter is calculated and reported as a %change from baseline.

Outcome measures

Outcome measures
Measure
Endpoint
n=4 Participants
After 6 months of 14:10 daily fasting regimen
Baseline
n=4 Participants
Prior to intervention start
Macrovascular Endothelial Function
4.96 %change from baseline
Interval 2.61 to 9.91
8.20 %change from baseline
Interval 4.15 to 15.02

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: This secondary outcome was not assessed due to technical issues with equipment, which was malfunctioning during the study period and could not be replaced due to funding issues. None of the recruited participants completed this assessment.

Transcutaneous deep tissue oxygen saturation will be measured using the inSpectra near infrared device. The data are calculated and reported as a %change from baseline.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: This secondary outcome was not assessed due to technical issues with equipment, which was malfunctioning during the study period and could not be replaced due to funding issues. None of the recruited participants completed this assessment.

The arterial stiffness will be measured using the pulse wave analysis approach (SphygmoCor, Atcor medical, Itasca IL, or similar). Analysis generated the augmentation index which will be used for comparison before and after treatment.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: This secondary outcome was not assessed due to technical issues with equipment, which was malfunctioning during the study period and could not be replaced due to funding issues. None of the recruited participants completed this assessment.

ECG will be recorded for heart rate variability analysis. The values of high frequency domain, low frequency domain, their ratio, as well as total power will be calculated and used for comparison before and after treatment.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: No data were collected for this secondary outcome measure due to participants unwillingness to undergo examination because it requires a camera to be placed under their tongue for several minutes. None of the recruited participants completed this assessment.

Video recordings of the sublingual vasculature will be performed using the high definition video camera GlycoCheck (Microvascular health solutions). Data collected will include perfused boundary region (um), and will be used for comparison before and after treatment.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: No data were collected for this secondary outcome measure due to participants unwillingness to undergo examination because it requires a camera to be placed under their tongue for several minutes. None of the recruited participants completed this assessment.

Video recordings of the sublingual vasculature will be performed using the high definition video camera GlycoCheck (Microvascular health solutions). Data collected will include capillary density (mm/mm\^2), and will be used for comparison before and after treatment.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: No data were collected for this secondary outcome measure due to participants unwillingness to undergo examination because it requires a camera to be placed under their tongue for several minutes. None of the recruited participants completed this assessment.

Video recordings of the sublingual vasculature will be performed using the high definition video camera GlycoCheck (Microvascular health solutions). Data collected will include red blood cell velocity (um/sec), and will be used for comparison before and after treatment.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: Secondary completers only included in the reporting.

Flanker Inhibitory Control and Attention Test was used to assess inhibitory control and attention. The participant is asked to focus on a particular stimulus while inhibiting attention to the stimuli flanking it. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

Outcome measures

Outcome measures
Measure
Endpoint
n=6 Participants
After 6 months of 14:10 daily fasting regimen
Baseline
n=6 Participants
Prior to intervention start
Inhibitory Control and Attention
50 T score
Interval 42.0 to 57.0
44 T score
Interval 36.0 to 61.0

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: Secondary completers only included in the reporting.

Picture Sequence Memory Test was used to assess episodic memory. Participants are shown a number of activities, and then asked to reproduce the sequence of pictures as it was presented to them. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

Outcome measures

Outcome measures
Measure
Endpoint
n=6 Participants
After 6 months of 14:10 daily fasting regimen
Baseline
n=6 Participants
Prior to intervention start
Episodic Memory
54 T score
Interval 45.0 to 58.0
56 T score
Interval 49.0 to 63.0

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: Secondary completers only included in the reporting.

List Sorting Working Memory Test was used to assess working memory. The participant is asked to recall and sequence different stimuli that are presented visually and via audio. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

Outcome measures

Outcome measures
Measure
Endpoint
n=6 Participants
After 6 months of 14:10 daily fasting regimen
Baseline
n=6 Participants
Prior to intervention start
Working Memory
51 T score
Interval 40.0 to 70.0
55 T score
Interval 33.0 to 66.0

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: Secondary completers only included in the reporting.

Picture Vocabulary Test measures receptive vocabulary administered in a computer-adaptive test (CAT) format. Respondents select the picture that most closely matches the meaning of the word. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

Outcome measures

Outcome measures
Measure
Endpoint
n=6 Participants
After 6 months of 14:10 daily fasting regimen
Baseline
n=6 Participants
Prior to intervention start
Language
51 T score
Interval 33.0 to 60.0
51 T score
Interval 44.0 to 63.0

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: Secondary completers only included in the reporting

Dimensional Change Card Sort Test was used to assess cognitive flexibility and attention. The participant is asked to match a series of picture pairs to a target picture. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

Outcome measures

Outcome measures
Measure
Endpoint
n=6 Participants
After 6 months of 14:10 daily fasting regimen
Baseline
n=6 Participants
Prior to intervention start
Executive Function
65 T score
Interval 45.0 to 81.0
63 T score
Interval 45.0 to 75.0

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: Secondary completers only included in the reporting.

Pattern Comparison Processing Speed Test was used to assess processing speed. Participants are asked to quickly determine whether two stimuli are the same or not the same. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

Outcome measures

Outcome measures
Measure
Endpoint
n=6 Participants
After 6 months of 14:10 daily fasting regimen
Baseline
n=6 Participants
Prior to intervention start
Processing Speed
58 T score
Interval 44.0 to 72.0
53 T score
Interval 42.0 to 78.0

Adverse Events

Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Andriy Yabluchanskiy

University of Oklahoma Health Sciences Center

Phone: 405-271-8001

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place